Harvard Bioscience (HBIO) Current Deferred Tax Assets (2010 - 2015)
Harvard Bioscience (HBIO) posted quarterly Current Deferred Tax Assets of $42000.0 for Q4 2015, down 97.23% year-over-year from $1.5 million in Q4 2014, and down 98.36% quarter-over-quarter from $2.6 million in Q3 2015.
Harvard Bioscience (HBIO) Current Deferred Tax Assets (2010 - 2015) Analysis & Trends
Harvard Bioscience (HBIO) has reported Current Deferred Tax Assets for 6 consecutive years, with $42000.0 the latest figure, recorded in Q4 2015.
- In Q4 2015, Current Deferred Tax Assets fell 97.23% year-over-year to $42000.0; the TTM figure through Dec 2015 stood at $42000.0 (down 97.23% YoY), while the FY2015 annual figure was $42000.0, down 97.23% from the prior year.
- Current Deferred Tax Assets declined to $42000.0 in Q4 2015 per HBIO's latest filing, from $2.6 million in the prior quarter.
- Across five years, Current Deferred Tax Assets topped out at $5.7 million in Q3 2011 and bottomed at $42000.0 in Q4 2015.
- Historically, Current Deferred Tax Assets has averaged $2.5 million across 5 years, with a median of $1.6 million in 2013.
- On a YoY basis, Current Deferred Tax Assets climbed as much as 68.8% in 2015 and fell as far as 97.23% in 2015.
- Harvard Bioscience's Current Deferred Tax Assets stood at $3.9 million in 2011, then sank by 60.26% to $1.6 million in 2012, then declined by 0.39% to $1.5 million in 2013, then fell by 2.07% to $1.5 million in 2014, then sank by 97.23% to $42000.0 in 2015.
- Business Quant data shows HBIO's Current Deferred Tax Assets at $42000.0 in Q4 2015, $2.6 million in Q3 2015, and $2.6 million in Q2 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Harvard Bioscience | 33.45 Mn | 26.94 Mn | 12.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | 42,000.00 |
| Dec 31, 2015 | 42,000.00 |
| Sep 30, 2015 | 2.56 Mn |
| Sep 30, 2015 | 2.56 Mn |
| Jun 30, 2015 | 2.61 Mn |
| Jun 30, 2015 | 2.61 Mn |
| Mar 31, 2015 | 1.86 Mn |
| Mar 31, 2015 | 1.86 Mn |
| Dec 31, 2014 | 1.52 Mn |
| Dec 31, 2014 | 1.52 Mn |
| Sep 30, 2014 | 1.55 Mn |
| Sep 30, 2014 | 1.55 Mn |
| Jun 30, 2014 | 1.55 Mn |
| Jun 30, 2014 | 1.55 Mn |
| Mar 31, 2014 | 1.55 Mn |
| Mar 31, 2014 | 1.55 Mn |
| Dec 31, 2013 | 1.55 Mn |
| Dec 31, 2013 | 1.55 Mn |
| Sep 30, 2013 | 1.56 Mn |
| Sep 30, 2013 | 1.56 Mn |